X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-18 | A | Agilent Technologies, Inc. | Brown Judy L | Dir | S - Sale | $116.53 | -8 | 1,677 | 0% | -$904 | ||||||
2025-06-13 | SEER | Seer, Inc. | Nishar Dipchand | Dir | S - Sale | $2.08 | -30,253 | 49,204 | -38% | -$62,935 | ||||||
| M | 2025-06-12 | QTRX | Quanterix Corp | Walt David R | Dir | P - Purchase | $6.16 | +160,000 | 1,866,933 | +9% | +$984,968 | |||||
2025-06-09 | QTRX | Quanterix Corp | Toloue Masoud | Pres, CEO | P - Purchase | $5.42 | +45,900 | 518,922 | +10% | +$248,723 | ||||||
| M | 2025-06-06 | QTRX | Quanterix Corp | Walt David R | Dir | P - Purchase | $5.40 | +210,000 | 1,706,933 | +14% | +$1,133,796 | |||||
2025-06-06 | QTRX | Quanterix Corp | Donnelly William P | Dir | P - Purchase | $5.44 | +93,113 | 139,094 | +203% | +$506,348 | ||||||
2025-06-06 | BRKR | Bruker Corp | Laukien Frank H | Pres, CEO, 10% | P - Purchase | $38.36 | +2,608 | 40,456,558 | 0% | +$100,043 | ||||||
2025-06-02 | CTKB | Cytek Biosciences, Inc. | McCombe William D. | CFO | P - Purchase | $2.78 | +35,000 | 55,746 | +169% | +$97,300 | ||||||
2025-05-29 | NAUT | Nautilus Biotechnology, Inc. | Mowry Anna | CFO, Treasurer | P - Purchase | $0.77 | +15,000 | 83,000 | +22% | +$11,489 | ||||||
2025-05-30 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $10.00 | +1,399 | 40,175 | +4% | +$13,986 | ||||||
2025-05-29 | RVTY | Revvity, Inc. | McMurry-Heath Michelle | Dir | S - Sale | $92.17 | -600 | 4,833 | -11% | -$55,299 | ||||||
| D | 2025-05-28 | MTD | Mettler Toledo International Inc/ | Kelly Michael A | Dir | S - Sale+OE | $1,159.93 | -1,062 | 1,748 | -38% | -$1,231,846 | |||||
2025-05-23 | LAB | Standard Biotools Inc. | Kim Hanjoon Alex | CFO | S - Sale | $0.94 | -1,428 | 930,286 | 0% | -$1,344 | ||||||
2025-05-23 | LAB | Standard Biotools Inc. | Mackay Sean | SVP, Chief Business Officer | S - Sale | $0.94 | -13,217 | 843,076 | -2% | -$12,437 | ||||||
2025-05-23 | LAB | Standard Biotools Inc. | Egholm Michael | Pres, CEO | S - Sale | $0.94 | -5,473 | 2,741,191 | 0% | -$5,150 | ||||||
2025-05-27 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $9.80 | +101 | 38,776 | 0% | +$990 | ||||||
2025-05-22 | LAB | Standard Biotools Inc. | Kim Hanjoon Alex | CFO | S - Sale | $1.00 | -1,355 | 931,714 | 0% | -$1,358 | ||||||
2025-05-22 | LAB | Standard Biotools Inc. | Egholm Michael | Pres, CEO | S - Sale | $1.00 | -5,116 | 2,746,664 | 0% | -$5,126 | ||||||
2025-05-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $8.30 | -9,343 | 1,320,342 | -1% | -$77,540 | ||||||
2025-05-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $8.30 | -7,485 | 448,374 | -2% | -$62,120 | ||||||
2025-05-22 | TXG | 10X Genomics, Inc. | Taich Adam | CFO | S - Sale | $8.30 | -4,044 | 331,588 | -1% | -$33,562 | ||||||
2025-05-23 | AVTR | Avantor, Inc. | Summe Gregory L | Dir | P - Purchase | $12.50 | +30,000 | 158,111 | +23% | +$375,000 | ||||||
2025-05-22 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $9.33 | +500 | 38,675 | +1% | +$4,665 | ||||||
| M | 2025-05-21 | LAB | Standard Biotools Inc. | Mackay Sean | SVP, Chief Business Officer | S - Sale | $1.02 | -25,374 | 856,293 | -3% | -$25,784 | |||||
2025-05-21 | LAB | Standard Biotools Inc. | Egholm Michael | Pres, CEO | S - Sale | $1.03 | -4,719 | 2,751,780 | 0% | -$4,861 | ||||||
2025-05-21 | LAB | Standard Biotools Inc. | Kim Hanjoon Alex | CFO | S - Sale | $1.03 | -1,407 | 933,069 | 0% | -$1,449 | ||||||
2025-05-22 | AVTR | Avantor, Inc. | Summe Gregory L | Dir | P - Purchase | $12.65 | +20,000 | 128,111 | +18% | +$253,000 | ||||||
2025-05-21 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $9.27 | +8,035 | 73,350 | +12% | +$74,474 | ||||||
| AM | 2025-05-19 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $8.43 | +4,965 | 30,140 | +20% | +$41,868 | |||||
2025-05-20 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale | $2.08 | -6,760 | 443,629 | -2% | -$14,028 | ||||||
2025-05-20 | SEER | Seer, Inc. | Farokhzad Omid | CEO, CHAIR | S - Sale | $2.08 | -33,663 | 1,306,060 | -3% | -$69,854 | ||||||
| M | 2025-05-19 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $8.43 | +4,965 | 30,140 | +20% | +$41,868 | |||||
2025-05-19 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $1.00 | -5,195 | 269,259 | -2% | -$5,200 | ||||||
| M | 2025-05-16 | EYPT | Eyepoint Pharmaceuticals, Inc. | Zaderej Karen L. | Dir | P - Purchase | $5.90 | +10,000 | 36,500 | +38% | +$59,000 | |||||
| D | 2025-04-18 | SCND | Scientific Industries Inc | Moore John A | COB | P - Purchase | $1.00 | +35,000 | 139,782 | +33% | +$35,000 | |||||
| D | 2025-04-18 | SCND | Scientific Industries Inc | Blechman Michael | Dir | P - Purchase | $1.00 | +10,000 | 10,000 | New | +$10,000 | |||||
| D | 2025-04-18 | SCND | Scientific Industries Inc | Nicols John J | Dir | P - Purchase | $1.00 | +15,000 | 30,000 | +100% | +$15,000 | |||||
| M | 2025-05-14 | EYPT | Eyepoint Pharmaceuticals, Inc. | Zaderej Karen L. | Dir | P - Purchase | $5.45 | +10,000 | 26,500 | +61% | +$54,450 | |||||
2025-05-12 | ILMN | Illumina, Inc. | Dhingra Ankur | SVP, CFO | P - Purchase | $81.21 | +6,100 | 24,906 | +32% | +$495,381 | ||||||
| M | 2025-05-12 | ILMN | Illumina, Inc. | Thaysen Jacob | CEO | P - Purchase | $80.86 | +12,350 | 83,390 | +17% | +$998,674 | |||||
| M | 2025-05-08 | NAUT | Nautilus Biotechnology, Inc. | Mallick Parag | Chief Scientist, 10% | P - Purchase | $0.73 | +13,500 | 20,493,392 | 0% | +$9,885 | |||||
2025-05-07 | AVTR | Avantor, Inc. | Summe Gregory L | Dir | P - Purchase | $12.00 | +25,000 | 50,000 | +100% | +$300,000 | ||||||
| D | 2025-02-28 | LCTC | Lifeloc Technologies, Inc | Heim Michelle | Controller | S - Sale+OE | $3.80 | -1,500 | 0 | -100% | -$5,700 | |||||
2025-04-29 | AVTR | Avantor, Inc. | Massaro Joseph R | Dir | P - Purchase | $12.30 | +8,100 | 35,038 | +30% | +$99,630 | ||||||
2025-04-28 | AVTR | Avantor, Inc. | Summe Gregory L | Dir | P - Purchase | $12.50 | +25,000 | 66,011 | +61% | +$312,500 | ||||||
2025-04-28 | AVTR | Avantor, Inc. | Kang Lan | Dir | P - Purchase | $12.57 | +5,000 | 35,215 | +17% | +$62,850 | ||||||
2025-04-28 | AVTR | Avantor, Inc. | Peacock Jonathan M | Dir | P - Purchase | $12.81 | +8,091 | 202,715 | +4% | +$103,646 | ||||||
| D | 2025-04-18 | SCND | Scientific Industries Inc | Bleichroeder LP | 10% | P - Purchase | $1.00 | +250,000 | 1,453,351 | +21% | +$250,000 | |||||
2025-02-28 | LCTC | Lifeloc Technologies, Inc | Kornelsen Vern D | CFO | P - Purchase | $3.80 | +12,250 | 2,134,245 | +1% | +$46,550 | ||||||
| AD | 2025-02-28 | LCTC | Lifeloc Technologies, Inc | Siecke Donald E. | Dir | P - Purchase | $3.80 | +16,000 | 555,352 | +3% | +$60,800 | |||||
2019-10-02 | LCTC | Lifeloc Technologies, Inc | Siecke Donald E. | Dir | P - Purchase | $1.57 | +9,347 | 460,295 | +2% | +$14,675 | ||||||
| D | 2025-04-04 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.65 | -25,343 | 191,374 | -12% | -$16,473 | |||||
| D | 2025-04-04 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.65 | -1,523 | 84,803 | -2% | -$990 | |||||
2025-04-02 | PRPO | Precipio, Inc. | Sabet Ahmed Zaki | COO | P - Purchase | $6.00 | +79 | 939 | +9% | +$474 | ||||||
| D | 2025-04-01 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.71 | -6,816 | 65,328 | -9% | -$4,839 | |||||
2025-03-31 | A | Agilent Technologies, Inc. | Podolsky Daniel K | Dir | S - Sale | $116.46 | -1,819 | 35,737 | -5% | -$211,844 | ||||||
| M | 2025-03-19 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $1.00 | +77,233 | 17,236,232 | 0% | +$76,918 | |||||
| D | 2025-03-14 | BIOBI | Bio-Rad Laboratories, Inc. | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $247.06 | -3,000 | 8,171 | -27% | -$741,184 | |||||
2025-03-17 | A | Agilent Technologies, Inc. | Gonsalves Rodney | VP, Corporate Controller | S - Sale | $121.98 | -1,908 | 21,826 | -8% | -$232,691 | ||||||
2025-03-10 | BRKR | Bruker Corp | Bures Thomas | Chief Accounting Officer | P - Purchase | $47.40 | +500 | 3,472 | +17% | +$23,698 | ||||||
2025-03-06 | A | Agilent Technologies, Inc. | Rataj Sue H. | Dir | S - Sale | $126.38 | -6,971 | 19,640 | -26% | -$881,009 | ||||||
2025-03-03 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.41 | -12,497 | 2,225,357 | -1% | -$17,583 | ||||||
2025-03-03 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $1.41 | -6,486 | 1,497,695 | 0% | -$9,126 | ||||||
2025-03-03 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $1.41 | -2,973 | 184,619 | -2% | -$4,183 | ||||||
2025-02-28 | LCLC | Lifeloc Technologies, Inc | Edco Partners Lllp | 10% | P - Purchase | $3.80 | +34,800 | 2,100,119 | +2% | +$132,240 | ||||||
2025-02-28 | LCTC | Lifeloc Technologies, Inc | Kashenberg Adam W. | Dir | P - Purchase | $3.80 | +1,000 | 1,000 | New | +$3,800 | ||||||
2025-02-28 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.07 | +4,820,959 | 19,490,326 | +33% | +$5,134,321 | ||||||
| D | 2025-02-28 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale+OE | $10.63 | -7,942 | 1,158,257 | -1% | -$84,393 | |||||
| M | 2025-02-26 | AVTR | Avantor, Inc. | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $17.44 | -4,532 | 86,605 | -5% | -$79,036 | |||||
| M | 2025-02-26 | AVTR | Avantor, Inc. | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $17.44 | -5,940 | 39,571 | -13% | -$103,581 | |||||
| D | 2025-02-26 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $1.09 | -535 | 52,144 | -1% | -$583 | |||||
2025-02-24 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $11.07 | -4,573 | 335,324 | -1% | -$50,603 | ||||||
2025-02-24 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $11.07 | -5,092 | 1,116,199 | 0% | -$56,346 | ||||||
| D | 2025-02-24 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,313.69 | -790 | 734 | -52% | -$1,037,815 | |||||
2025-02-21 | TXG | 10X Genomics, Inc. | Mateo Alan | Dir | P - Purchase | $11.14 | +40,000 | 61,691 | +184% | +$445,572 | ||||||
2025-02-18 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $1.88 | -24,349 | 187,592 | -11% | -$45,727 | ||||||
2025-02-18 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $1.88 | -100,773 | 1,496,681 | -6% | -$189,252 | ||||||
2025-02-18 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.88 | -259,909 | 2,237,854 | -10% | -$488,109 | ||||||
2025-02-18 | BRKR | Bruker Corp | Laukien Frank H | Pres, CEO, 10% | P - Purchase | $50.92 | +20,000 | 40,453,678 | 0% | +$1,018,330 | ||||||
| D | 2025-02-14 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $19.89 | -800 | 143,310 | -1% | -$15,912 | |||||
2025-02-11 | MTD | Mettler Toledo International Inc/ | De La Guerroniere Marc | Head of Eur, NA Market Orgs | S - Sale | $1,331.89 | -888 | 0 | -100% | -$1,182,719 | ||||||
| D | 2025-02-10 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,351.34 | -600 | 6 | -99% | -$810,806 | |||||
2025-02-06 | RVTY | Revvity, Inc. | McMurry-Heath Michelle | Dir | S - Sale | $119.49 | -1,970 | 3,021 | -39% | -$235,395 | ||||||
2025-02-04 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale | $2.24 | -3,550 | 476,961 | -1% | -$7,940 | ||||||
2025-02-04 | SEER | Seer, Inc. | Farokhzad Omid | CEO, CHAIR | S - Sale | $2.24 | -8,068 | 1,428,217 | -1% | -$18,044 | ||||||
| D | 2025-02-03 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $1.35 | -485 | 163,434 | 0% | -$655 | |||||
| D | 2025-01-30 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale+OE | $126.73 | -15,170 | 97,109 | -14% | -$1,922,513 | |||||
2025-01-21 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $150.00 | -1,911 | 39,652 | -5% | -$286,650 | ||||||
2025-01-10 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $2.03 | -34,405 | 1,597,454 | -2% | -$69,980 | ||||||
| D | 2025-01-07 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale+OE | $116.81 | -5,492 | 19,652 | -22% | -$641,543 | |||||
| A | 2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $5.88 | -12,000 | 24,050 | -33% | -$70,506 | |||||
| A | 2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $6.10 | +15,000 | 24,050 | +166% | +$91,430 | |||||
| A | 2024-11-11 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $6.03 | -2,000 | 16,525 | -11% | -$12,056 | |||||
| D | 2024-12-16 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $20.16 | -180 | 142,203 | 0% | -$3,629 | |||||
2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $6.20 | -12,000 | 24,050 | -33% | -$74,400 | ||||||
2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $5.80 | +15,000 | 24,050 | +166% | +$87,000 | ||||||
| M | 2024-12-03 | RPID | Rapid Micro Biosystems, Inc. | Pei Melinda Litherland | Dir | P - Purchase | $1.02 | +20,000 | 54,300 | +58% | +$20,364 | |||||
| D | 2024-12-03 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,254.09 | -140 | 6 | -96% | -$175,573 | |||||
2024-12-03 | AXDX | Accelerate Diagnostics, Inc | Patience John | Dir | P - Purchase | $1.57 | +200,000 | 871,211 | +30% | +$314,000 | ||||||
2024-12-03 | AXDX | Accelerate Diagnostics, Inc | Schuler Jack W | Dir, 10% | S - Sale | $1.57 | -200,000 | 8,336,110 | -2% | -$314,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |